Appropriate use of PCSK9 Inhibitors in India

The burden of atherosclerotic cardiovascular (CV) disease is alarmingly high and increasing in our country. Dyslipidemia is one of the major modifiable risk factors, and INTERHEART study showed that dyslipidemia had the highest population attributable risk for myocardial infarction. In the managemen...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the Association of Physicians of India 2019-04, Vol.67 (4), p.74-85
Hauptverfasser:	Iyengar, S S, Bansal, Manish, Sawhney, Jps, Wander, Gurpreet, Narasingan, S N, Chandra, K Sarat, D, Prabhakar, Nair, Tiny, Krishnakumar, B, Deshpande, Nitin, Bardoloi, Neil, Shetty, Sadananda, Desai, Nagaraj, Pancholia, A K, Swamy, Ajay
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!